mswalker
@mswalker
@Invivyd - I’m ready to call it. This drug is incredible. Long Haulers need it. Just a couple of weeks along, I’m seeing what others w/ Long COVID report. These antibodies are powerful- WE NEED A TRIAL!! @polybioRF? My nightmare began in Jan ‘24. Today I feel Perfect 🥳
PEMGARDA infusion, 24 days ago: Today =>> Paris, easily walking the steep incline, to Montmartre- carrying the backpack 😵 this follows multiple 15,000 step days. My kids don’t even ask if I’m feeling ok anymore. I’m just feeling so completely normal again & feeling pretty…
Feels like a trend many are noticing: Early wave LHers reporting more instances of improvement with earlier mAbs. If this holds true, I hope we're able to quickly (locate existing?) or reinstate some of those older gen products. First wave LHers can't wait any longer 🙏…
@Invivyd Sotrovimab seems to have been extremely effective in earlier variant Covid strains, as people here can attest to. Apparently there is still a ton of it sitting on shelves. Just throwing that out there. :)
So glad to join this SPEAR Study Group! LongCOVID & Post Vaccine Syndrome patients have waited way too long for expanded research on how #monoclonal antibodies - including those with broadly neutralizing activity - may improve their symptoms. We intend to change that!
So glad to join this SPEAR Study Group! LongCOVID & Post Vaccine Syndrome patients have waited way too long for expanded research on how #monoclonal antibodies - including those with broadly neutralizing activity - may improve their symptoms. We intend to change that!
Wow - @Invivyd so much enthusiasm from Long Haulers for #Pemgarda! How are governments not interested in making this available so people can get back to WORK $$ and back to *LIFE*?!? Lots of info & stories here: mabsforlongcovid.wordpress.com #mAbsForLongCovid #ReleaseTheMABS
The overwhelming number of experiences I read about mAbs for Long Covid are positive… we need a Pemgarda trial for Long Covid persistence @Invivyd
So glad to join this SPEAR Study Group! LongCOVID & Post Vaccine Syndrome patients have waited way too long for expanded research on how #monoclonal antibodies - including those with broadly neutralizing activity - may improve their symptoms. We intend to change that!
Someone improved on Ensitrelvir and Sipavibart … Are there any trials with this combo? @polybioRF @longcovidlabs @OpenMedF #longcovid